Elsevier
Elsevier is a global information analytics company that publishes scientific, technical, and medical content and provides data and software tools for researchers, clinicians, and institutions. It generates revenue primarily through journal and book subscriptions, article processing charges for open access, and licenses for research, clinical decision support, and education platforms. Its products serve academic institutions, corporations, healthcare providers, and governments worldwide.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 1880
- Headquarters
- Amsterdam-Zuidoost, Netherlands
Elsevier customers on Arbolus
Customers who reviewed Elsevier
Seniority of Elsevier customers
The largest group of people who reviewed Elsevier holds Director roles (45%), followed by C-Suite (39%) and Manager (17%).
- Director 45%
- C-Suite 39%
- Manager 17%
Customers sample
Employer names and spend open in the full report, along with the other 119 customers.
What 122 Arbolus experts think of Elsevier
Overall sentiment: Positive
NPS distribution: 57.6% Promoters, 30.5% Passives, 11.9% Detractors, with an NPS score of 45.8 and average NPS of 8.36. Renewal intent is strong, with 64.4% likely to renew, 15.6% not renewing, and 20% unsure. 73.7% of customers have used the platform for more than one year, indicating high stickiness. Key feedback themes include trusted content, workflow integration, and the critical role of Elsevier in regulatory and clinical environments.
Everything 122 customers told us about Elsevier.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
47 Net Promoter Score, from 122 scored reviews- Promoters 71
- Passives 38
- Detractors 13
Praised
- AI-Enabled Personalization
- AI for Evidence Synthesis
- Standardization and Scalability in Education
- Trusted, Comprehensive Content
Criticised
- Need for More Personalization and Integration
- Cost and Complexity
- Manual Effort for Synthesis
- Switching Driven by Cost and Functionality
What Elsevier customers say
Standardization and Scalability in Education
“I would recommend the tool to a peer, particularly an organization that needs a reliable, evidence-based nursing education and competency solution at scale. The combination of established clinical content, standardized learning, assessment capabilities, and reporting makes it valuable for organizations with large or geographically dispersed nursing workforces.”
Trusted, Comprehensive Content
“I would recommend Elsevier to peers who need reliable access to high-quality scientific and technical information, particularly in pharmaceutical R&D, regulatory affairs and other evidence-intensive functions. Its main strengths are the breadth and credibility of its content, established scientific coverage and ability to provide traceable source information.”
Critical for Clinical and Regulatory Workflows
“I would recommend Elsevier, particularly Embase, to peers who are performing formal biomedical literature reviews, clinical evaluations, or other evidence-generation activities where comprehensive and reproducible searching is important. Its main strengths are the breadth of biomedical literature coverage, structured indexing, and the ability to build detailed search strategies that can be documented and repeated.”
Renewal intent
Plan to renew 65%Plan to renew, by seniority
- 75% 16 answers
- 71% 21 answers
- 43% 7 answers
- 0% 2 answers
- 8.7/10 Average score from customers who will renew
- 7/10 Average score from undecided customers
- 7.6/10 Average score from customers not renewing
Report
For people who use Elsevier
Do you use Elsevier at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 122 customers of Elsevier have already contributed
Takes a few minutes. Your identity stays anonymous.